Could the MED13 mutations manifest as a Kabuki‐like syndrome?
- 30 November 2020
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (2) , 584-590
Abstract
MED13‐related disorder is a new neurodevelopmental disorder recently described in literature, which belongs to the group of CDK8‐kinase module genes‐associated conditions. It is characterized by variable intellectual disability and/or developmental delays, especially in language. Autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), eye or vision problems, hypotonia, mild congenital hearth abnormalities and dysmorphisms have been described among individuals with MED13 mutations. We report the case of a 13‐year‐old girl who received a previous clinical diagnosis of Kabuki syndrome (KS) without mutations in classic KS genes. After a whole exome sequencing (WES) analysis a de novo missense mutation in MED13 (c.C979T; p.Pro327Ser) was found. This variant has been once described in literature as accountable for a novel neurodevelopmental disorder. The aim of this report is to improve clinical delineation of MED13‐related condition and to explore differences and similarities between KS spectrum and MED13‐related disorders.Keywords
Funding Information
- Ministry of Health (RC 17_31)
This publication has 22 references indexed in Scilit:
- De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental DisorderThe American Journal of Human Genetics, 2019
- Kabuki syndrome: international consensus diagnostic criteriaJournal of Medical Genetics, 2018
- De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?Pediatric Research, 2016
- Redefining the MED13L syndromeEuropean Journal of Human Genetics, 2015
- Kabuki syndrome: clinical and molecular characteristicsKorean Journal of Pediatrics, 2015
- H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiationeLife, 2013
- MED12 related disordersAmerican Journal of Medical Genetics Part A, 2013
- The SCF–Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with MediatorGenes & Development, 2013
- The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator functionGenes & Development, 2009
- Structural organization of yeast and mammalian mediator complexesProceedings of the National Academy of Sciences, 2000